Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 658

1.

Retrospective Two-Center Study on Prepubertal Children with Tinea Capitis in Korea.

Lee W, Lee EH, Bang YJ, Jun JB.

Mycoses. 2019 Oct 9. doi: 10.1111/myc.13014. [Epub ahead of print]

PMID:
31596519
2.

HER2-targeted therapies - a role beyond breast cancer.

Oh DY, Bang YJ.

Nat Rev Clin Oncol. 2019 Sep 23. doi: 10.1038/s41571-019-0268-3. [Epub ahead of print] Review.

PMID:
31548601
3.

Molecular basis for retinol binding by serum amyloid A during infection.

Hu Z, Bang YJ, Ruhn KA, Hooper LV.

Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19077-19082. doi: 10.1073/pnas.1910713116. Epub 2019 Sep 4.

4.

Minimal Effects of Binaural Auditory Beats for Subclinical Insomnia: A Randomized Double-Blind Controlled Study.

Bang YR, Choi HY, Yoon IY.

J Clin Psychopharmacol. 2019 Sep/Oct;39(5):499-503. doi: 10.1097/JCP.0000000000001097.

PMID:
31433343
5.

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer.

Park H, Bang JH, Nam AR, Eun Park J, Hua Jin M, Bang YJ, Oh DY.

Sci Rep. 2019 Jul 31;9(1):11131. doi: 10.1038/s41598-019-47330-1.

6.

Characteristics of adolescents who visit the emergency department following suicide attempts: comparison study between adolescents and adults.

Lee J, Bang YS, Min S, Ahn JS, Kim H, Cha YS, Park IS, Kim MH.

BMC Psychiatry. 2019 Jul 26;19(1):231. doi: 10.1186/s12888-019-2213-5.

7.

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.

Kim JW, Lee KH, Kim JW, Suh KJ, Nam AR, Bang JH, Bang YJ, Oh DY.

Br J Cancer. 2019 Aug;121(4):332-339. doi: 10.1038/s41416-019-0523-5. Epub 2019 Jul 17.

PMID:
31312030
9.

Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.

Jin MH, Nam AR, Park JE, Bang JH, Bang YJ, Oh DY.

Cancer Res Treat. 2019 Jun 25. doi: 10.4143/crt.2019.183. [Epub ahead of print]

10.

Anesthetic Consideration for Peroral Endoscopic Myotomy.

Bang YS, Park C.

Clin Endosc. 2019 Jul 10. doi: 10.5946/ce.2019.033. [Epub ahead of print] Review.

11.

Usefulness of patellar cartilage cross-sectional area for knee tibiofemoral osteoarthritis in elderly.

Bang YS, Park J, Kim J, Choi YS, Lim YS, Cho HR, Kim YU.

Clin Interv Aging. 2019 Jun 5;14:1021-1026. doi: 10.2147/CIA.S205027. eCollection 2019.

12.

Value of Anterior Band of the Inferior Glenohumeral Ligament Area as a Morphological Parameter of Adhesive Capsulitis.

Bang YS, Park J, Lee SY, Park J, Park S, Joo Y, Kim YU, Lee YK.

Pain Res Manag. 2019 May 7;2019:9301970. doi: 10.1155/2019/9301970. eCollection 2019.

13.

Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity during Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study.

Yoo SH, Kang SY, Cheon GJ, Oh DY, Bang YJ.

J Nucl Med. 2019 Jun 14. pii: jnumed.119.226407. doi: 10.2967/jnumed.119.226407. [Epub ahead of print]

PMID:
31201247
14.

A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors.

Oh DY, Lee KW, Han SW, Kim JW, Shin JW, Jo SJ, Won J, Hahn S, Lee H, Kim WH, Bang YJ.

Oncologist. 2019 Aug;24(8):1037-e636. doi: 10.1634/theoncologist.2019-0294. Epub 2019 Jun 4.

15.

Epithelial retinoic acid receptor β regulates serum amyloid A expression and vitamin A-dependent intestinal immunity.

Gattu S, Bang YJ, Pendse M, Dende C, Chara AL, Harris TA, Wang Y, Ruhn KA, Kuang Z, Sockanathan S, Hooper LV.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10911-10916. doi: 10.1073/pnas.1812069116. Epub 2019 May 16.

16.

Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer.

Kim HS, Hwang IG, Min HY, Bang YJ, Kim WH.

Oncol Lett. 2019 May;17(5):4383-4392. doi: 10.3892/ol.2019.10132. Epub 2019 Mar 8.

17.

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.

Shaw AT, Riely GJ, Bang YJ, Kim DW, Camidge DR, Solomon BJ, Varella-Garcia M, Iafrate AJ, Shapiro GI, Usari T, Wang SC, Wilner KD, Clark JW, Ou SI.

Ann Oncol. 2019 Jul 1;30(7):1121-1126. doi: 10.1093/annonc/mdz131.

18.

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer.

Kim TY, Han HS, Lee KW, Zang DY, Rha SY, Park YI, Kim JS, Lee KH, Park SH, Song EK, Jung SA, Lee N, Kim YH, Cho JY, Bang YJ.

Gastric Cancer. 2019 Apr 3. doi: 10.1007/s10120-019-00958-4. [Epub ahead of print]

PMID:
30945121
19.

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.

Hellmann MD, Kim TW, Lee CB, Goh BC, Miller WH, Oh DY, Jamal R, Chee CE, Chow LQM, Gainor JF, Desai J, Solomon BJ, Das Thakur M, Pitcher B, Foster P, Hernandez G, Wongchenko MJ, Cha E, Bang YJ, Siu LL, Bendell J.

Ann Oncol. 2019 Jul 1;30(7):1134-1142. doi: 10.1093/annonc/mdz113.

PMID:
30918950
20.

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.

Bang YJ, Kang YK, Catenacci DV, Muro K, Fuchs CS, Geva R, Hara H, Golan T, Garrido M, Jalal SI, Borg C, Doi T, Yoon HH, Savage MJ, Wang J, Dalal RP, Shah S, Wainberg ZA, Chung HC.

Gastric Cancer. 2019 Jul;22(4):828-837. doi: 10.1007/s10120-018-00909-5. Epub 2019 Mar 25.

21.

Electroacupuncture for chemotherapy-induced anorexia through humoral appetite regulation: A preliminary experimental study.

Kang KS, Huh W, Bang Y, Choi HJ, Baek JY, Song JH, Kang JW, Kim TH.

Exp Ther Med. 2019 Apr;17(4):2587-2597. doi: 10.3892/etm.2019.7250. Epub 2019 Feb 7.

22.

Small-molecule inhibitor of HlyU attenuates virulence of Vibrio species.

Lee ZW, Kim BS, Jang KK, Bang YJ, Kim S, Ha NC, Jung YH, Lee HJ, Han HJ, Kim JS, Kim J, Sahu PK, Jeong LS, Kim MH, Choi SH.

Sci Rep. 2019 Mar 13;9(1):4346. doi: 10.1038/s41598-019-39554-y.

23.

Dorsal and ventral thoracic 12 vertebra body height is associated with incident lumbar vertebral fracture in postmenopausal osteoporotic women.

Bang YS, Lee S, Kang KN, Lee J, Jeong HW, Choi SI, Kim YU.

Clin Interv Aging. 2019 Feb 15;14:375-380. doi: 10.2147/CIA.S199402. eCollection 2019.

24.

Phonon Boost Effect on the S±-wave Superconductor with Incipient Band.

Bang Y.

Sci Rep. 2019 Mar 7;9(1):3907. doi: 10.1038/s41598-019-40536-3.

25.

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.

Park JE, Jin MH, Hur M, Nam AR, Bang JH, Won J, Oh DY, Bang YJ.

Gastric Cancer. 2019 Sep;22(5):932-940. doi: 10.1007/s10120-019-00943-x. Epub 2019 Feb 27.

PMID:
30815759
26.

KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer.

Bang YJ, Van Cutsem E, Fuchs CS, Ohtsu A, Tabernero J, Ilson DH, Hyung WJ, Strong VE, Goetze TO, Yoshikawa T, Tang LH, Hwang PMT, Webb N, Adelberg D, Shitara K.

Future Oncol. 2019 Mar;15(9):943-952. doi: 10.2217/fon-2018-0581. Epub 2019 Feb 19.

27.

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors.

Jung KH, LoRusso P, Burris H, Gordon M, Bang YJ, Hellmann MD, Cervantes A, de Olza MO, Marabelle A, Hodi FS, Ahn MJ, Emens LA, Barlesi F, Hamid O, Calvo E, McDermott D, Soliman H, Rhee I, Lin R, Pourmohamad T, Suchomel J, Tsuhako A, Morrissey K, Mahrus S, Morley R, Pirzkall A, Davis SL.

Clin Cancer Res. 2019 Jun 1;25(11):3220-3228. doi: 10.1158/1078-0432.CCR-18-2740. Epub 2019 Feb 15.

PMID:
30770348
28.

SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.

van den Boorn HG, Abu-Hanna A, Ter Veer E, van Kleef JJ, Lordick F, Stahl M, Ajani JA, Guimbaud R, Park SH, Dutton SJ, Bang YJ, Boku N, Mohammad NH, Sprangers MAG, Verhoeven RHA, Zwinderman AH, van Oijen MGH, van Laarhoven HWM.

Cancers (Basel). 2019 Feb 5;11(2). pii: E187. doi: 10.3390/cancers11020187.

29.

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).

Berry S, Giraldo N, Nguyen P, Green B, Xu H, Ogurtsova A, Soni A, Succaria F, Wang D, Roberts C, Stein J, Engle E, Pardoll D, Anders R, Cottrell T, Taube JM, Tran B, Voskoboynik M, Kuo J, Bang YL, Chung HC, Ahn MJ, Kim SW, Perera A, Freeman D, Achour I, Faggioni R, Xiao F, Ferte C, Lemech C, Meric-Bernstam F, Werner T, Hodi S, Messersmith W, Lewis N, Talluto C, Dostalek M, Tao A, McWhirter S, Trujillo D, Luke J, Xu C, BoMarelli, Qi J, Qin G, Yu H, Jenkins M, Lo KM, Halle JP, Lan Y, Taylor M, Vogelzang N, Cohn A, Stepan D, Shumaker R, Dutcus C, Guo M, Schmidt E, Rasco D, Brose M, Vogelzang N, Di Simone C, Jain S, Richards D, Encarnacion C, Rasco D, Shumaker R, Dutcus C, Stepan D, Guo M, Schmidt E, Taylor M, Vogelzang N, Encarnacion C, Cohn A, Di Simone C, Rasco D, Richards D, Taylor M, Dutcus C, Stepan D, Shumaker R, Guo M, Schmidt E, Mier J, An J, Yang YY, Lee WH, Yang J, Kim JK, Kim HG, Paek SH, Lee JW, Woo J, Kim JB, Kwon H, Lim W, Paik NS, Kim YK, Moon BI, Janku F, Tan D, Martin-Liberal J, Takahashi S, Geva R, Gucalp A, Chen X, Subramanian K, Mataraza J, Wheler J, Bedard P.

J Immunother Cancer. 2019 Feb 13;7(1):46. doi: 10.1186/s40425-019-0519-y.

30.

Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β.

Ji SI, Park JH, You HG, Chi HJ, Bang YW, Cha SH.

Immunol Lett. 2019 Mar;207:46-55. doi: 10.1016/j.imlet.2019.01.009. Epub 2019 Jan 23.

PMID:
30684504
31.

Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.

Moon YJ, Kim JW, Bang YS, Lim YS, Ki Y, Sang BH.

PLoS One. 2019 Jan 25;14(1):e0209100. doi: 10.1371/journal.pone.0209100. eCollection 2019. Erratum in: PLoS One. 2019 Mar 13;14(3):e0213967.

32.

Multivalent Traptavidin-DNA Conjugates for the Programmable Assembly of Nanostructures.

Kim YY, Bang Y, Lee AH, Song YK.

ACS Nano. 2019 Feb 26;13(2):1183-1194. doi: 10.1021/acsnano.8b06170. Epub 2019 Jan 23.

PMID:
30654610
33.

Multidimensional Comparison of Cancer-Related Fatigue and Chronic Fatigue Syndrome: The Role of Psychophysiological Markers.

Park HY, Jeon HJ, Bang YR, Yoon IY.

Psychiatry Investig. 2019 Jan;16(1):71-79. doi: 10.30773/pi.2018.10.26. Epub 2019 Jan 7.

34.

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer.

Bang YJ, Kang YK, Ng M, Chung HC, Wainberg ZA, Gendreau S, Chan WY, Xu N, Maslyar D, Meng R, Chau I, Ajani JA.

Eur J Cancer. 2019 Feb;108:17-24. doi: 10.1016/j.ejca.2018.11.017. Epub 2018 Dec 25.

PMID:
30592991
35.

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028.

Ott PA, Bang YJ, Piha-Paul SA, Razak ARA, Bennouna J, Soria JC, Rugo HS, Cohen RB, O'Neil BH, Mehnert JM, Lopez J, Doi T, van Brummelen EMJ, Cristescu R, Yang P, Emancipator K, Stein K, Ayers M, Joe AK, Lunceford JK.

J Clin Oncol. 2019 Feb 1;37(4):318-327. doi: 10.1200/JCO.2018.78.2276. Epub 2018 Dec 13.

PMID:
30557521
36.

Projected lifetime cancer risks from occupational radiation exposure among diagnostic medical radiation workers in South Korea.

Lee WJ, Choi Y, Ko S, Cha ES, Kim J, Kim YM, Kong KA, Seo S, Bang YJ, Ha YW.

BMC Cancer. 2018 Dec 4;18(1):1206. doi: 10.1186/s12885-018-5107-x.

37.

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.

Nam AR, Jin MH, Park JE, Bang JH, Oh DY, Bang YJ.

Cancer Res Treat. 2019 Jul;51(3):1167-1179. doi: 10.4143/crt.2018.526. Epub 2018 Dec 3.

38.

A validation study on three screening questionnaires for obstructive sleep apnea in a Korean community sample.

Jeon HJ, Bang YR, Yoon IY.

Sleep Breath. 2019 Sep;23(3):969-977. doi: 10.1007/s11325-018-1748-x. Epub 2018 Nov 17.

PMID:
30448963
39.

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.

Moehler M, Ryu MH, Dvorkin M, Lee KW, Coşkun HŞ, Wong R, Chung HC, Poltoratsky A, Tsuji A, Yen CJ, Muntean AS, Le Sourd S, Vaccaro GM, Overton L, Boku N, Wainberg ZA, Patel M, Sharma M, Xiong H, Conti I, Taieb J, Bang YJ.

Future Oncol. 2019 Feb;15(6):567-577. doi: 10.2217/fon-2018-0668. Epub 2018 Oct 31.

40.

Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology.

Ha H, Bang JH, Nam AR, Park JE, Jin MH, Bang YJ, Oh DY.

Cancer Res Treat. 2019 Apr;51(2):832-840. doi: 10.4143/crt.2018.311. Epub 2018 Oct 5.

41.

Icariin Improves Functional Behavior in a Mouse Model of Traumatic Brain Injury and Promotes Synaptic Plasticity Markers.

Joo H, Bae J, Lee JS, Bang Y, Lee BJ, Park JW, Lee K, Cho JH, Bu Y.

Planta Med. 2019 Feb;85(3):231-238. doi: 10.1055/a-0753-0400. Epub 2018 Oct 9.

PMID:
30300905
42.

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.

Nam AR, Kim JW, Park JE, Bang JH, Jin MH, Oh DY, Bang YJ.

Cancer Res Treat. 2019 Jul;51(3):886-900. doi: 10.4143/crt.2018.375. Epub 2018 Oct 1.

43.

Case Series Study on the Use of BU Pharmacopuncture Treatment in Patients with Acute Lumbar Sprain.

Yang M, Jang J, Cha E, Ahn B, Bang Y, Song B, Shin J, Ahn C, Kim D, Kim S.

J Pharmacopuncture. 2018 Jun;21(2):120-125. doi: 10.3831/KPI.2018.21.015. Epub 2018 Jun 30.

44.

Abnormal hippocampal neurogenesis in Parkinson's disease: relevance to a new therapeutic target for depression with Parkinson's disease.

Lim J, Bang Y, Choi HJ.

Arch Pharm Res. 2018 Oct;41(10):943-954. doi: 10.1007/s12272-018-1063-x. Epub 2018 Aug 22. Review.

PMID:
30136247
45.

Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.

Kim M, Kim M, Yoo HJ, Bang YJ, Lee SH, Lee JH.

Clin Genet. 2018 Nov;94(5):438-444. doi: 10.1111/cge.13439. Epub 2018 Sep 7.

PMID:
30132804
46.

Low But Continuous Occurrence of Microsporum gypseum Infection in the Study on 198 Cases in South Korea from 1979 to 2016.

Lee WJ, Park JH, Kim JY, Jang YH, Lee SJ, Bang YJ, Jun JB.

Ann Dermatol. 2018 Aug;30(4):427-431. doi: 10.5021/ad.2018.30.4.427. Epub 2018 Jun 28.

47.

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.

Bang YJ, Ruiz EY, Van Cutsem E, Lee KW, Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J.

Ann Oncol. 2018 Oct 1;29(10):2052-2060. doi: 10.1093/annonc/mdy264.

48.

Frontal Sinus Osteoplastic Flap Surgery Using a Surgical Navigation System.

Bang YJ, Lim BW, Ha R, Woo JH, Kim ST, Jung JH, Cha HE, Chang JS, Han JH, Choi JY, Kang IG.

J Craniofac Surg. 2018 Oct;29(7):e662-e663. doi: 10.1097/SCS.0000000000004729.

PMID:
30015739
49.

Effects of Dangguisusan, a prescription of Korean medicine on controlled cortical impact-induced traumatic brain injury mouse model.

Jung JY, Joo H, Bae J, Bang Y, Lee BJ, Cho JH, Park JW, Lee K, Bu Y.

J Ethnopharmacol. 2018 Oct 28;225:198-201. doi: 10.1016/j.jep.2018.07.015. Epub 2018 Jul 20.

PMID:
30009978
50.

Mortality among diagnostic medical radiation workers in South Korea, 1996-2015.

Lee WJ, Ko S, Bang YJ, Cha ES, Lee KM.

Occup Environ Med. 2018 Oct;75(10):739-741. doi: 10.1136/oemed-2018-105019. Epub 2018 Jun 30.

PMID:
29960954

Supplemental Content

Support Center